Benjamin L. Lampson

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

Benjamin L. Lampson, Siddha Kasar, Tiago R. Matos et al. · Blood · 2016 · 284 citations · Full text

Rare Codons Regulate KRas Oncogenesis

Benjamin L. Lampson, Nicole L. Pershing, Joseph A. Prinz et al. · Current Biology · 2012 · 150 citations · Full text

Genetics, Genomic Mechanism, Gene Regulation +3

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes

Christopher G. Duncan, Patrick Killela, Cathy A. Payne et al. · Oncotarget · 2010 · 117 citations · Full text

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

Matthew S. Davids, Benjamin L. Lampson, Svitlana Tyekucheva et al. · The Lancet Oncology · 2021 · 100 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +10

Rare codons capacitate Kras-driven de novo tumorigenesis

Nicole L. Pershing, Benjamin L. Lampson, Jason A. Belsky et al. · Journal of Clinical Investigation · 2014 · 78 citations · Full text

Chromatin, Systems Biology, Rare Codons +11